Revisiting the EAU Paediatric Urology Guideline Risk Grouping On Vesicoureteral Reflux: Shall We Challenge Ourselves?
PDF
Cite
Share
Request
Original Investigation
P: 0-0
October 2016

Revisiting the EAU Paediatric Urology Guideline Risk Grouping On Vesicoureteral Reflux: Shall We Challenge Ourselves?

GMJ 2016;27(4):0-0
1. Osmangazi University Faculty of Medicine, Department of Urology
2. Gazi University Faculty of Medicine, Department of Urology
3. özel eryaman hastanesi, Ankara
4. Pamukkale University Faculty of Medicine, Department of Urology
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

Conclusion:

We detected over treatment in low risk group. Success of the surgical correction was evident in moderate and high-risk group. The surgeon should be more pursuer in low risk and more invasive in moderate and high-risk group.

Results:

A total of 157 patients with 232 renal units (RU) were treated due to VUR. 33(71.7%) of 46RU’s were treated with sub-ureteric injection and 18(39.1%) unsuccessful RU’s were treated with re-injection in low risk group. Only 2(11.1%) re-injected RU’s had postoperative UTI and/or new renal scar at follow-up. In moderate risk group, 54 and 7 of 61 unsuccessful RU’s were treated with re-injection and ureteral re-implantation, respectively. 4(7.4%) of 54 had postoperative UTI and/or new renal scar at follow-up. In high-risk group, 13 and 12 of 25 unsuccessful RU’s treated with re-injection and ureteral re-implantation, respectively.

Methods:

The records of the patients who received medical and/or surgical treatment between 2009-2012 due to VUR were reviewed. History, demographic variables, diagnostic features (presence of renal scar, grade of reflux, laterality), clinical course, causes of failure, secondary intervention type and follow-up variables were analyzed. The patients were classified as low, moderate and high-risk groups according to EAU paediatric urology guideline. Treatment failure is defined as new urinary tract infection and presence of new renal scar during follow-up.

Objective:

To challenge retrospectively the treatment outcomes of vesicoureteral reflux (VUR) management according to new EAU Paediatric Urology Guideline Risk Grouping on VUR.